Details for New Drug Application (NDA): 086841
✉ Email this page to a colleague
The generic ingredient in DAPSONE is dapsone. There are eight drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the dapsone profile page.
Summary for 086841
Tradename: | DAPSONE |
Applicant: | Everest Life Sci |
Ingredient: | dapsone |
Patents: | 0 |
Suppliers and Packaging for NDA: 086841
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DAPSONE | dapsone | TABLET;ORAL | 086841 | ANDA | AvKARE | 42291-008 | 42291-008-01 | 100 TABLET in 1 BOTTLE (42291-008-01) |
DAPSONE | dapsone | TABLET;ORAL | 086841 | ANDA | Jacobus Pharmaceutical Company, Inc. | 49938-102 | 49938-102-30 | 2 BLISTER PACK in 1 CARTON (49938-102-30) / 15 TABLET in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription